Efficacy and safety of rivaroxaban in prevention and therapy of thromboembolic events in patients with nonvalvular atrial fibrillation

Context: Rivaroxaban is an oral direct factor Xa inhibitor reducing the risk of systemic embolism and stroke in patients with nonvalvular atrial fibrillation. Aims: The primary objective was to evaluate the effectiveness of rivaroxaban therapy in reducing the risk of systemic embolism and stroke in...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Tamara Kovačević Preradovic, Siniša Miljković, Ljiljana Kos, Aziz Šukalo, Una Glamočlija, Amna Tanović Avdić, Meliha Mehić
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wolters Kluwer Medknow Publications 2023-01-01
Schriftenreihe:	Journal of the Practice of Cardiovascular Sciences
Schlagworte:	nonvalvular atrial fibrillation rivaroxaban stroke systemic embolism
Online-Zugang:	http://www.j-pcs.org/article.asp?issn=2395-5414;year=2023;volume=9;issue=2;spage=110;epage=115;aulast=Preradovic
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!